Announcements
19 May 2025
Metabolites | Selected Papers Published in 2023–2024 Related to NAFLD
We are delighted to share some highly cited papers on NAFLD research that were published in our journal Metabolites (ISSN: 2218-1989) in 2023–2024. In addition, some Special Issues related to this topic are currently open for submission.
The following is a list of articles and Special Issues that we believe will be interest of you:
1. “Bilirubin Nanoparticle Treatment in Obese Mice Inhibits Hepatic Ceramide Production and Remodels Liver Fat Content”
by Zachary A. Kipp, Genesee J. Martinez, Evelyn A. Bates, Agil B. Maharramov, Robert M. Flight, Hunter N. B. Moseley, Andrew J. Morris, David E. Stec and Terry D. Hinds, Jr.
Metabolites 2023, 13(2), 215; https://doi.org/10.3390/metabo13020215
Available online: https://www.mdpi.com/2218-1989/13/2/215
2. “Metabolic Role of Autophagy in the Pathogenesis and Development of NAFLD”
by Lingxuan An, Ulrich Wirth, Dominik Koch, Malte Schirren, Moritz Drefs, Dionysios Koliogiannis, Hanno Niess, Joachim Andrassy, Markus Guba, Alexandr V. Bazhin et al.
Metabolites 2023, 13(1), 101; https://doi.org/10.3390/metabo13010101
Available online: https://www.mdpi.com/2218-1989/13/1/101
3. “Screening for NAFLD—Current Knowledge and Challenges”
by Roberta Forlano, Giordano Sigon, Benjamin H. Mullish, Michael Yee and Pinelopi Manousou
Metabolites 2023, 13(4), 536; https://doi.org/10.3390/metabo13040536
Available online: https://www.mdpi.com/2218-1989/13/4/536
4. “Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease—Current Background, Hopes, and Perspectives”
by Georgiana-Diana Cazac, Cristina-Mihaela Lăcătușu, Gabriela Ștefănescu, Cătălina Mihai, Elena-Daniela Grigorescu, Alina Onofriescu and Bogdan-Mircea Mihai
Metabolites 2023, 13(5), 581; https://doi.org/10.3390/metabo13050581
Available online: https://www.mdpi.com/2218-1989/13/5/581
5. “Plasma Metabolite Signatures in Male Carriers of Genetic Variants Associated with Non-Alcoholic Fatty Liver Disease”
by Lilian Fernandes Silva, Jagadish Vangipurapu, Anniina Oravilahti, Ville Männistö and Markku Laakso
Metabolites 2023, 13(2), 267; https://doi.org/10.3390/metabo13020267
Available online: https://www.mdpi.com/2218-1989/13/2/267
6. “Adipose Tissue Insulin Resistance in South Asian and Nordic Women after Gestational Diabetes Mellitus”
by Ahalya Anita Suntharalingam Kvist, Archana Sharma, Christine Sommer, Elisabeth Qvigstad, Hanne Løvdal Gulseth, Stina Therese Sollid, Ingrid Nermoen, Naveed Sattar, Jason Gill, Tone Møller Tannæs et al.
Metabolites 2024, 14(5), 288; https://doi.org/10.3390/metabo14050288
Available online: https://www.mdpi.com/2218-1989/14/5/288
7. “The Cellular Stability Hypothesis: Evidence of Ferroptosis and Accelerated Aging-Associated Diseases as Newly Identified Nutritional Pentadecanoic Acid (C15:0) Deficiency Syndrome”
by Stephanie Venn-Watson
Metabolites 2024, 14(7), 355; https://doi.org/10.3390/metabo14070355
Available online: https://www.mdpi.com/2218-1989/14/7/355
Special Issues:
|
“Liver Injury and Regeneration—Metabolic Research”
|
“Metabolomics in Human Diseases and Health”
|
|
“Metabolomics and MASLD: Pathways, Biomarkers, and Clinical Insights”
|
“Metabolic Dysregulation in Fatty Liver Disease”
|
